BioSpace News Archive

Business

Veracyte Appoints Jonathan Wygant as Chief Accounting Officer

Veracyte, Inc. today announced that it has appointed Jonathan Wygant as chief accounting officer, effective immediately.

February 22, 2022

·

2 min read

Sinovac Amends Shareholder Rights Plan - Feb 22, 2022

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that its board of directors has amended its shareholder rights plan.

February 22, 2022

·

2 min read

BioCapital

New Credentialing and Access Management SaaS, Venduur, Warns of CMS/Omnibus Phase-Two Vaccination Mandate Deadlines Set for February 28

Venduur (https://venduur.com/) highlighted the importance of a recent U.S. Supreme Court ruling that upheld the CMS Mandate requiring policies and procedures be in place to ensure all healthcare facilities, business associates, and subcontractors be vaccinated for COVID-19.

February 22, 2022

·

3 min read

Pharm Country

Delcath Systems Announces Move to a Direct Sales & Marketing Model for CHEMOSAT®

Delcath Systems, Inc. announced that effective March 1, 2022, it will resume direct responsibility for sales, marketing and distribution activities relating to the CHEMOSAT® Hepatic Delivery System in Europe.

February 22, 2022

·

1 min read

Biotech Beach

Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO’22

Progenity, Inc. today shared two poster presentations that were presented during the 17th Congress of the European Crohn’s and Colitis Organisation (ECCO) on February 18, 2022.

February 22, 2022

·

6 min read

Biotech Beach

Sorrento Announces COVISHIELD (STI-9167) Antibody Strongly Neutralizes BA.2 Omicron Sublineage Virus as Well as BA.1 and BA.1+R346k Omicron Viruses

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that additional preclinical results demonstrate broad spectrum COVISHIELD (STI-9167) neutralizing activity against Omicron BA.1, Omicron BA.1+R346K, and the increasingly prevalent sublineage, Omicron BA.2.

February 22, 2022

·

8 min read

Business

Praxis Precision Medicines to Provide Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), today announced that it will provide a corporate update and report financial results for the fourth quarter and full year 2021 on Monday, February 28, 2022, before the U.S. financial markets open.

February 22, 2022

·

1 min read

New Study from PerfectServe: Emoji Trends in Clinical Communications

PerfectServe®, a leading provider of cloud-based clinical collaboration and provider scheduling solutions, today published a report analyzing the use of emoji in clinical settings.

February 22, 2022

·

4 min read

Business

Provectus Announces New Executive Appointment Ushering in the Next Stage of Growth

Provectus Algae (Provectus), an Australian synthetic biology company specializing in microalgal biomanufacturing technologies for the production of specialty ingredients for a wide array of industries and applications, announced today the appointment of Dr Claudia Vickers as Chief Scientific Officer.

February 22, 2022

·

3 min read

Business

Sumitomo Dainippon Pharma Oncology Appoints Jatin J. Shah, M.D. as Chief Medical Officer

Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage pharmaceutical company focused on research and development for novel cancer therapeutics, today announced the appointment of Jatin J. Shah, M.D. as Executive Vice President, Chief Medical Officer and Global Head of Development.

February 22, 2022

·

4 min read